PharmaEngine : Announcement of cancellation of the Company treasury shares and change of paid-in capital registration

Close

Today's Information

Provided by: PharmaEngine, Inc.
SEQ_NO	1	Date of announcement	2022/03/01	Time of announcement	18:41:33
Subject	Announcement of cancellation of the Company treasury shares and change of paid-in capital registration
Date of events	2022/02/25	To which item it meets	paragraph 36
Statement	1.Date of the competent authority's approval of capital reduction:2022/02/25 2.Date of completion of capitalization change registration:2022/02/25 3.Effect on the financial statements (including any discrepancy between the amount of paid-in capital and the no.of shares outstanding, and the effect on net worth per share): (1)The paid-in capital was NT$1,465,968,400. The paid-in capital after the cancellation of treasury shares is NT$1,455,968,400. (2)The number of shares outstanding was 146,596,840 shares. The number of shares outstanding after the cancellation of treasury shares is 145,596,840 shares. The difference is 1,000,000 shares. (3)The net asset value per share was NT$26.12 before cancellation. It is NT$26.3 after cancellation. (based on Q3 2021 data) 4.Plan for expected exchange of shares:NA 5.Estimated no.of listed common shares after capital reduction and new issue:NA 6.Estimated no.of listed common shares as a percentage of issued common shares after capital reduction and new issue (No.of common shares after capital reduction/No.of issued common shares):NA 7.Countermeasures for poor circulation of equity if the aforesaid estimated no.of listed common shares does not reach 5 million shares and the percentage does not reach 25% after capital reduction:NA 8.Any other matters that need to be specified: The change of registration for this capital reduction is approved by the Ministry of Economic Affairs by the Letter Jing-Shou-Shang-Zi No. 11101028990. The Company received the letter of approval on 2022/03/01.